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Since atrial natriuretic factor (ANF) inhibits angiotensin II (ANGII)-induced mesangial cell contraction, 
we studied its effect on cytosolic free calcium in fura-2-1oaded monolayers. ANF lowered basal calcium from 
117 + 5 to 89 + 2 nM, and also reduced the ANGII-induced calcium transient. The absolute level of cyto- 
solic calcium after ANGII was lower in cells preincubated with ANF compared to buffer. In a few cell lines, 
ANF had no effect on cytosolic alcium, while in all cell lines ANF had inhibited contraction. Thus, while 
ANF has effects on cytosolic alcium in mesangial cells, the vasorelaxant effects of ANF may require addi- 
tional physiologic interactions. 
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1. INTRODUCTION 
Atrial natriuretic factor (ANF) has well-known 
vasorelaxant properties [1]. In particular, we have 
shown that atriopeptin III (APIII) inhibits 
angiotensin II (ANGII)-induced contraction of 
cultured rat glomerular mesangial cells while the 
shorter fragment atriopeptin I (API) has no such 
effect [2]. Recent evidence in vascular smooth 
muscle suggests that ANF-induced vasorelaxation 
may be related to effects on cytosolic free calcium 
[3]. Therefore, we studied the effect of ANF on 
cytosolic free calcium in cultured rat glomerular 
mesangial cells, which have properties in common 
with vascular smooth muscle [4]. 
2. MATERIALS AND METHODS 
The synthetic rat atrial natriuretic peptides 
atriopeptin I (AP1) and atriopeptin III (APIII) 
were purchased from Bachem (Torrance, CA). 
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ANGII and arginine-vasopressin (AVP) were pur- 
chased from Calbiochem (San Diego, CA). 
Glomerular mesangial cells were started from 
isolated glomeruli using the method of Lovett et al. 
[5]. Primary cultures were incubated for approx. 1 
week until the cells approached confluence. The 
cells were subcultured, and experiments were per- 
formed on monolayers from passages 2-4. 
In order to measure cytosolic free calcium, 
monolayers were grown on plastic coverslips 
(Aclar type 33c, Allied Engineered Plastics, 
Pottsville, PA). Prior to experiments, the cells 
were loaded with 1/~M fluorescent Ca 2+ indicator 
fura-2 acetoxy methyl ester (Molecular Probes, 
Eugene, OR). The loaded coverslips were placed 
diagonally in a quartz cuvette containing Krebs- 
Henseleit-Hepes (KHH) buffer. Fluorescence was 
monitored continuously before and after addition 
of agonists using a single excitation wavelength of 
339 nm, and an emission wavelength of 500 nm. 
These studies were performed at 37°C with con- 
stant mixing utilizing a fluorometer designed by 
the Johnson Foundation Biomedical Instrumenta- 
tion Group. Cytosolic free calcium was calculated 
from the fura-2 signal using previously described 
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formulae [6] after calibration of the signal by addi- 
tion of 40/~M ionomycin (maximal fluorescence) 
followed by 7.5 mM EGTA/60 mM Tris-HCl, pH 
10.5 (minimal fluorescence). 
Experimental incubations designed to measure 
mesangial cell cyclic GMP (cGMP) responses were 
performed on mesangial cell monolayers. 
Triplicate determinations of cGMP were made of 
each experimental condition in each cell line. Dose- 
response data for the effect of APIII on in- 
tracellular cGMP were generated by the addition 
of the agonist at time zero, followed by a 3 min in- 
cubation that was ended by the removal of the ex- 
perimental media followed by the addition of 
0.1 N HCI, which extracts intracellular cyclic 
nucleotides from cell monolayers, cGMP was 
measured by radioimmunoassay, utilizing ~2~I- 
tyrosine methyl ester cGMP (New England 
Nuclear) and rabbit antisera to cGMP (Kew Scien- 
tific). All samples were performed in duplicate 
after acetylation. There was no cross-reactivity of
the cGMP antisera with APIII, 0.1 N HC1, or in- 
cubation media. Cellular protein was measured in 
each culture dish after an overnight digestion with 
1 N NaOH according to Lowry et al. [7]. 
Results are expressed as means + SE. Statistical 
significance was determined by use of Student's t- 
test for unpaired data. Data were considered 
statistically significant if p < 0.05. 
3. RESULTS 
Fig.1 portrays actual calcium fluorescence trac- 
ings under a variety of circumstances. In panels 
A -C ,  ANGII caused a dose-dependent i crease in 
cytosolic free calcium with threshold at less than 
1 nM. Basal calcium was approx. 125 nM. Panel D 
indicates that AVP was a somewhat more potent 
agonist han ANGII. Panel E points out that prein- 
cubation with EGTA lowered basal cytosolic 
calcium, but there was no change in the initial 
calcium transient induced by AVP. However, there 
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Fig.l. Continuous calcium fluorescence tracings in fura-2-1oaded monolayers of cultured rat mesangial cells. (A-C) 
Dose response to ANGII. (D) Effect of AVP. (E) Effect of EGTA followed by AVP. 
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was a marked increase in the rate of return to 
basal. This indicates that there are two phases to 
the agonist-induced calcium increase; an initial 
transient based mainly on release from in- 
tracellular stores; and a sustained phase that is 
dependent to some extent on extracellular calcium. 
In fig.2, panel A shows that a 3 min incubation 
with KHH buffer containing 1.25 mM calcium had 
no effect on basal cytosolic free calcium. In panel 
B, API I I  (100 nM) added at time zero promptly 
resulted in a significant decrease in basal cytosolic 
free calcium. In this case, calcium dropped from 
119 to 86 nM, a 28% decrease. The effect of API I I  
was prolonged, with only a very slight recovery 
after 3 min. The addition of 10 nM ANGII  
promptly increased cytosolic free calcium to 
200 nM. The magnitude of this transient was 
slightly reduced compared to that seen in cells 
preincubated with buffer alone. In panel C, 1/zM 
API reduced basal calcium by 15% from 119 to 
101 nM; there was no inhibitory effect seen on the 
ANGII-induced transient. Panel D superimposes 
the tracings from panels A -C .  It can be seen that 
the absolute level of calcium reached after ANGII  
was significantly less in cells preincubated with 
API I I  compared to either API or KHH. 
There was no effect of API I I  or API on 
cytosolic free calcium in 5 of 11 cell lines tested. In 
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Fig.2. Continuous calcium fluorescence tracings in 
fura-2-1oaded monolayers of cultured rat mesangial 
cells. Effects of preincubation with KHH buffer (A), 
APIII (B), and API (C). Panel D compares tracings. 
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Table 1 
Mesangial cell cytosolic free calcium (nM) 
Condition R NR n 
Basal 117 ___ 5 113 + 3 10 
Post ANGII 304 + 16 289 + 19 10 
Studies were performed in fura-2-1oaded monolayers. 
Values represent means + SE. R, responding cells; NR, 
non-responding cells. See text for details. ANGII 
concentration, 10 nM 
the 6 cell lines that did respond, the results were 
very reproducible, with all monolayers howing 
similar findings. The cell lines that were 
nonresponsive to ANF in terms of cytosolic free 
calcium did respond appropriately to ANGII  and 
AVP. As shown in table 1, there were no dif- 
ferences in cytosolic free calcium seen in the basal 
state, or post ANGII,  in responding and 
nonresponding cells. In addition, as seen in table 2, 
API I I  stimulated intracellular cGMP accumula- 
tion in nonresponding cells to an extent similar to 
that seen in cells responding to ANF with 
decrements in cytosolic free calcium. Thus, the 
nonresponsive c ll lines probably still retain ANF 
receptors. 
Table 3 expands on fig.2D by summarizing all 
the data on those cell lines which did show changes 
in cytosolic free calcium in response to ANF. Note 
that API I I ,  and to a lesser extent API,  lowered 
basal cytosolic free calcium while KHH buffer had 
no such effect. The column labelled A represents 
the magnitude of the ANGII-induced calcium tran- 
Table 2 
Mesangial cell cGMP responses 
Concentration R NR n 
Basal 4.2 _+ 1.0 3.9 ___ 1.9 4 
APIII (10 -s M) 142 _+ 48 163 _+ 69 4 
APIII (10 -7 M) 1488 _+ 158 2031 _+ 198 a 4 
a p = 0.07 vs R, independent t-test 
Values represent means _+ SE of triplicate wells from 4 
different cell lines. Intracellular cGMP expressed as 
fmol//zg protein per 3 rain. R, responding cells; NR, 
nonresponding cells. See text for details 
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Table 3 
Mesangial cell cytosolic free calcium (nM) 
Agonist n Basal Post Post A 
agonist ANGII 
KHH 10 117_+ 5 117 +_ 5 304+_ 16 188 + 11 
APIII 16 114 + 3 89__+_ 2 a 213___ 10 a 124 +_ 10 a 
API 12 115 + 4 99 + 6 b 281 +_ 20 181 + 15 
a p < 0.001 VS KHH, independent t-test 
b p = 0.0504 vs KHH, independent t-test 
Studies were performed in fura-2-1oaded monolayers. A,
cytosolic free calcium post ANGII minus cytosolic free 
calcium post agonist (the magnitude of the calcium 
transient). Values represent means + SE. APIII 
concentration, 100 nM; API concentration, 1/~M 
sient. This was depressed only by API I I .  The net 
result of the decrease in basal and slight decrease 
in the transient was that the absolute level of 
cytosolic free calcium was lower in cells prein- 
cubated with API I I  compared to API  or buffer. 
4. DISCUSSION 
The explanation for the fact that not all cell lines 
respond to ANF with inhibitory effects on 
cytosolic free calcium remains unclear. The data in 
tables 1 and 2 indicate that the nonresponding cell 
lines are healthy and probably retain ANF recep- 
tors. Tissue culture itself certainly can alter in vivo 
cellular physiologic parameters and may be partly 
responsible for this dilemma. In addition, the 
presence of responding and nonresponding cell 
lines may indicate that there are subpopulations of
mesangial cells subserving different functions. 
The effect of ANF on cytosolic free calcium in 
vascular smooth muscle has been studied by 
others. Most investigators have found inhibitory 
effects although there has not been a uniformity of 
findings. Capponi et al. [8] found no effect of 
AP I I I  on cytosolic free calcium in quin2-1oaded rat 
aortic smooth muscle cells. On the other hand, 
Hassid [3] obtained inhibitory results very similar 
to those described herein in fura-2-1oaded rat aor- 
tic smooth muscle cells. Specifically, API I -  
decreased basal and vasoconstrictor-elevated 
cytosolic free calcium. Others have found no effect 
of ANF on basal calcium, but inhibitory effects on 
vasopressor-induced 45Ca efflux and/or influx 
[9-12]. In view of this lack of uniformity, it is dif- 
ficult to pinpoint whether ANF interferes with 
release of calcium from intracellular stores, or in- 
hibits calcium translocation through receptor- 
operated calcium channels, or enhances calcium 
extrusion, or some combination of these 
mechanisms. 
What is the physiologic role of these ANF- 
induced calcium changes in ANF-induced 
vasorelaxation? Our previous work [2] demon- 
strated that API I I  inhibited ANGII- induced con- 
traction of cultured rat glomerular mesangial cells. 
This effect was not seen with the shorter fragment 
API .  In the present work, fig.2D indicates that the 
absolute level of calcium reached after ANGI I  was 
significantly less in cells preincubated with API I I  
compared to either API  or buffer. Thus, there is a 
correlation between the functional response and 
the physiologic parameter suggesting the possibili- 
ty of a causal relationship. On the other hand, the 
inhibitory effect of API I I  on ANGII- induced 
mesangial cell contraction [2] was seen in all cell 
lines tested, while, as described above, the in- 
hibitory effects on cytosolic free calcium occurred 
in only 6 of 11 cell lines tested. This is a strong 
argument against the concept that ANF is 
vasorelaxant directly because of its effects on 
cytosolic free calcium. In this regard, a recent 
report studied the effect of ANF on calcium in rab- 
bit aortic strips utilizing aequorin as a calcium in- 
dicator [13]. In this study, ANF inhibited both the 
norepinephrine-induced calcium transient as well 
as the norepinephrine-induced contraction. 
However, ANF had no effect on the ANGI I -  
induced calcium transient while still significantly 
inhibiting the ANGII- induced contraction. Again, 
there is a dissociation between the physiologic 
parameter and the functional response. 
In summary, we believe that while ANF has ef- 
fects on cytosolic free calcium in vascular smooth 
muscle and glomerular mesangial cells, the 
vasorelaxant effects of ANF require additional, 
possibly more distal physiologic interactions. 
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